ArrowMark Colorado Holdings’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$36.8M Sell
569,789
-56,429
-9% -$3.98M 0.98% 27
2025
Q4
$42.1M Sell
626,218
-298,657
-32% -$20.1M 0.93% 34
2025
Q3
$67.8M Buy
924,875
+58,034
+7% +$3.85M 1.26% 20
2025
Q2
$45.1M Sell
866,841
-496,598
-36% -$28.3M 0.81% 40
2025
Q1
$87M Sell
1,363,439
-147,072
-10% -$8.54M 1.41% 17
2024
Q4
$72.2M Sell
1,510,511
-500,144
-25% -$25.6M 0.97% 32
2024
Q3
$115M Sell
2,010,655
-80,046
-4% -$4.59M 1.47% 17
2024
Q2
$109M Buy
2,090,701
+231,860
+12% +$10.2M 1.31% 19
2024
Q1
$75.6M Buy
1,858,841
+282,758
+18% +$10.6M 0.85% 37
2023
Q4
$58.3M Buy
1,576,083
+48,370
+3% +$1.82M 0.64% 53
2023
Q3
$58.4M Buy
1,527,713
+205,473
+16% +$8.42M 0.71% 46
2023
Q2
$47.7M Buy
1,322,240
+165,642
+14% +$5.65M 0.52% 61
2023
Q1
$44.2M Buy
+1,156,598
New +$54.3M 0.5% 59
2014
Q3
Sell
-20,000
Closed -$198K 304
2014
Q2
$198K Sell
20,000
-15,076
-43% -$128K 0.01% 316
2014
Q1
$446K Buy
35,076
+4,076
+13% +$60.5K 0.01% 247
2013
Q4
$465K Buy
31,000
+14,237
+85% +$183K 0.01% 245
2013
Q3
$185K Buy
+16,763
New +$140K 0.01% 292

Other funds holding HALO

ArrowMark Colorado Holdings's HALO Position: Q1 2026 in Review

ArrowMark Colorado Holdings reduced its Halozyme (HALO) stake by 9% in Q1 2026, selling an estimated $3.98M and leaving 569,789 shares worth $36.8M. The position accounts for 0.98% of the portfolio, ranked #27.

ArrowMark Colorado Holdings first reported a position in HALO in Q3 2013 and has held it in 17 quarters since. The position peaked at $115M in Q3 2024. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • ArrowMark Colorado Holdings held 569,789 shares of Halozyme worth $36.8M as of Q1 2026.
  • ArrowMark Colorado Holdings sold 56,429 Halozyme shares in Q1 2026, an estimated $3.98M.
  • Halozyme made up 0.98% of ArrowMark Colorado Holdings's portfolio in Q1 2026, its #27 holding.
  • ArrowMark Colorado Holdings first reported a position in Halozyme in Q3 2013 and has held it in 17 quarters since.
  • ArrowMark Colorado Holdings's Halozyme position peaked at $115M in Q3 2024.
  • 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on ArrowMark Colorado Holdings's 13F filing for Q1 2026, filed 15 May 2026.